- Home
- NXG vs OM Comparison
NXG vs OM Comparison
Compare NXG & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXG
- OM
- Stock Information
- Founded
- NXG 2012
- OM 2003
- Country
- NXG United States
- OM United States
- Employees
- NXG N/A
- OM N/A
- Industry
- NXG
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NXG
- OM Health Care
- Exchange
- NXG Nasdaq
- OM Nasdaq
- Market Cap
- NXG 211.3M
- OM 247.1M
- IPO Year
- NXG N/A
- OM 2020
- Fundamental
- Price
- NXG $48.69
- OM $13.74
- Analyst Decision
- NXG
- OM Hold
- Analyst Count
- NXG 0
- OM 1
- Target Price
- NXG N/A
- OM $22.00
- AVG Volume (30 Days)
- NXG 24.4K
- OM 160.2K
- Earning Date
- NXG 01-01-0001
- OM 11-05-2025
- Dividend Yield
- NXG 14.78%
- OM N/A
- EPS Growth
- NXG N/A
- OM N/A
- EPS
- NXG N/A
- OM N/A
- Revenue
- NXG N/A
- OM $119,304,000.00
- Revenue This Year
- NXG N/A
- OM $12.37
- Revenue Next Year
- NXG N/A
- OM $10.52
- P/E Ratio
- NXG N/A
- OM N/A
- Revenue Growth
- NXG N/A
- OM 2.47
- 52 Week Low
- NXG $30.32
- OM $5.85
- 52 Week High
- NXG $42.29
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- NXG 61.70
- OM 45.50
- Support Level
- NXG $45.80
- OM $13.30
- Resistance Level
- NXG $47.05
- OM $14.43
- Average True Range (ATR)
- NXG 0.66
- OM 0.63
- MACD
- NXG 0.31
- OM 0.15
- Stochastic Oscillator
- NXG 90.31
- OM 51.41
About NXG NXG NextGen Infrastructure Income Fund of Beneficial Interest
Cushing NextGen Infrastructure Income Fund is a closed-end investment management company. Its investment objective is to seek a high total return with a focus on current income. The Fund invests at least 80% of its net assets in a portfolio of equity and debt securities of infrastructure companies, including energy infrastructure companies, industrial infrastructure companies, sustainable infrastructure companies, and technology & communication infrastructure companies.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.